In a recent expanded access program involving 12 participants, jacifusen not only reduced neurofilament light chain (NfL)—a key marker of nerve damage—by up to 82.8%, but also demonstrated improvements in motor function in select patients, with one experiencing unprecedented recovery. This non-invasive treatment, administered via intrathecal injections, holds potential as a game-changer in managing ALS, particularly for Phoenix residents seeking cutting-edge care. At Center for Neurology and Spine (CNSe), we are committed to bringing innovative therapies like jacifusen to our Arizona community, offering hope to patients, families, and referring physicians. Read on to discover how this therapy, along with CNSe’s advanced neurodiagnostics and personalized care, is shaping the future of ALS treatment in Phoenix.
ALS, often called Lou Gehrig’s disease, progressively robs patients of motor function, leading to muscle weakness, paralysis, and ultimately death. While current treatments provide limited slowing of disease progression, there’s an urgent need for targeted, innovative therapies in Phoenix and beyond. At CNSe, we’re dedicated to offering advanced neurological care backed by cutting-edge research.
FUS-ALS is a specific form of ALS linked to mutations in the fused in sarcoma (FUS) gene. These mutations result in the buildup of toxic FUS protein in neurons, leading to neurodegeneration. Jacifusen, an antisense oligonucleotide (ASO) therapy, works by targeting FUS pre-mRNA, effectively reducing the production of the harmful FUS protein.
In a multi-center expanded access program involving 12 patients across the U.S. and Switzerland, researchers observed:
Up to 82.8% reduction in NfL levels, a biomarker of axonal injury and neurodegeneration.
Improved motor function in select participants, including one who showed remarkable functional recovery after 10 months.
Reduced FUS protein levels and FUS pathology in brain tissue from post-mortem analysis.
The study highlights jacifusen’s potential to transform ALS care. Traditional treatments focus on symptom management, but jacifusen offers a targeted, disease-modifying approach. Importantly for Phoenix patients, jacifusen’s administration via intrathecal injection avoids the need for invasive surgeries or complex drug regimens.
At CNSe, we’re committed to early adoption of innovative therapies. We work closely with neurologists, researchers, and referring physicians across Arizona to provide:
Personalized treatment plans for ALS patients.
Access to advanced neuroimaging and electromyography (EMG) to track disease progression.
Comprehensive care coordination to manage complex neurological conditions.
ALS is more than a disease; it affects the entire family. That’s why at CNSe, we prioritize:
Patient-centered care, ensuring comfort and dignity at every stage.
Family education and support, including resources to navigate the complex ALS journey.
Referring physician collaboration, streamlining diagnostics and treatment planning.
To boost our visibility on search engines, we focus on essential keywords like:
ALS treatment in Phoenix, AZ
Advanced ALS therapy in Arizona
Jacifusen and FUS-ALS care in Phoenix
Top neurologists in Phoenix
Neurology clinic for ALS near me
ALS research and care in Arizona
Intrathecal therapy for ALS Phoenix
Phoenix neurodegenerative disease specialists
While the recent study supports jacifusen’s potential, larger randomized clinical trials are ongoing to confirm its efficacy. At CNSe, we’re actively monitoring these developments to ensure our Phoenix community has timely access to emerging ALS treatments. As new data emerges, we’ll integrate these findings into our practice, offering hope to patients and families.
If you or a loved one are experiencing ALS symptoms, including muscle weakness, difficulty speaking, or unexplained fatigue, don’t wait. Contact Center for Neurology and Spine (CNSe) to schedule a consultation with our expert neurologists. Our team is committed to providing cutting-edge diagnostics, personalized treatment, and compassionate care for ALS and other neurological conditions in Phoenix, Scottsdale, Mesa, and across Arizona.